Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

G J Ossenkoppele, D A Breems, G Stuessi, Y van Norden, M Bargetzi, B J Biemond, P A von dem Borne, Y Chalandon, J Cloos, D Deeren, M Fehr, B Gjertsen, C Graux, G Huls, J J J W Janssen, A Jaspers, M Jongen-Lavrencic, E de Jongh, S K Klein, M van der KliftM van Marwijk Kooy, J Maertens, L Michaux, M W M van der Poel, A van Rhenen, L Tick, P Valk, M C Vekemans, W J F M van der Velden, O de Weerdt, T Pabst, M Manz, B Löwenberg, Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON), Swiss Group for Clinical Cancer Research (SAKK)

Research output: Contribution to journalErratum / corrigendum / retractionsAcademic

Original languageEnglish
Article number2820
Pages (from-to)2820-2820
Number of pages1
JournalLeukemia
Volume34
Issue number10
DOIs
Publication statusPublished - Oct 2020

Cite this